![Victoria Vakiener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victoria Vakiener
Directeur/Bestuurslid bij
ARROWHEAD PHARMACEUTICALS, INC.
Vermogen: 3 M $ op 31-07-2026
Profiel
Victoria Vakiener is an Independent Director at Arrowhead Pharmaceuticals, Inc. since 2022.
Former roles include Independent Director at Chimerix, Inc. from 2021 to 2025, Vice President at Janssen Pharmaceuticals, Inc. from 2018 to 2020, Chief Commercial Officer at Epizyme, Inc. from 2020 to 2021, and Vice President-Oncology Marketing at Janssen Oncology, Inc. from 2014 to 2018.
Education includes undergraduate studies at Albright College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-01-2026 | 35.723 ( 0,03% ) | 3 M $ | 31-07-2026 |
Actieve functies van Victoria Vakiener
| Bedrijven | Functie | Begin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 02-05-2022 |
Eerdere bekende functies van Victoria Vakiener
| Bedrijven | Functie | Einde |
|---|---|---|
| CHIMERIX, INC. | Directeur/Bestuurslid | 21-04-2025 |
| EPIZYME, INC. | Corporate Officer/Principal | 01-10-2021 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01-09-2020 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Corporate Officer/Principal | 01-12-2018 |
Opleiding van Victoria Vakiener
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Albright College
 Albright College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
